Raymond James & Associates’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$619M Buy
3,572,600
+106,584
+3% +$18.1M 0.38% 47
2024
Q2
$572M Buy
3,466,016
+326,928
+10% +$53.4M 0.38% 48
2024
Q1
$509M Buy
3,139,088
+83,441
+3% +$13.1M 0.35% 51
2023
Q4
$448M Buy
3,055,647
+6,894
+0.2% +$1.02M 0.33% 53
2023
Q3
$445M Sell
3,048,753
-26
-0% -$3.97K 0.37% 50
2023
Q2
$463M Buy
3,048,779
+19,875
+0.7% +$3M 0.38% 48
2023
Q1
$450M Buy
3,028,904
+77,052
+3% +$11M 0.39% 45
2022
Q4
$447M Buy
2,951,852
+68,269
+2% +$9.57M 0.41% 41
2022
Q3
$364M Buy
2,883,583
+143,744
+5% +$20.4M 0.37% 45
2022
Q2
$394M Buy
2,739,839
+150,729
+6% +$22.7M 0.39% 48
2022
Q1
$396M Sell
2,589,110
-100,771
-4% -$15.8M 0.33% 56
2021
Q4
$440M Buy
2,689,881
+81,673
+3% +$12.1M 0.35% 52
2021
Q3
$365M Buy
2,608,208
+33,785
+1% +$4.79M 0.33% 57
2021
Q2
$347M Buy
2,574,423
+26,080
+1% +$3.53M 0.32% 56
2021
Q1
$345M Sell
2,548,343
-17,483
-0.7% -$2.28M 0.35% 51
2020
Q4
$357M Buy
2,565,826
+29,425
+1% +$4.11M 0.39% 48
2020
Q3
$353M Sell
2,536,401
-37,980
-1% -$5.04M 0.44% 43
2020
Q2
$308M Sell
2,574,381
-325,183
-11% -$37.9M 0.41% 46
2020
Q1
$319M Sell
2,899,564
-65,863
-2% -$7.91M 0.51% 35
2019
Q4
$370M Buy
2,965,427
+31,944
+1% +$3.91M 0.47% 34
2019
Q3
$365M Sell
2,933,483
-334,626
-10% -$39.5M 0.51% 33
2019
Q2
$358M Sell
3,268,109
-213,348
-6% -$22.7M 0.52% 29
2019
Q1
$362M Buy
3,481,457
+53,655
+2% +$5.22M 0.55% 29
2018
Q4
$315M Buy
3,427,802
+293,985
+9% +$26.3M 0.55% 28
2018
Q3
$261M Sell
3,133,817
-15,011
-0.5% -$1.23M 0.4% 38
2018
Q2
$246M Buy
3,148,828
+66,876
+2% +$5.03M 0.41% 35
2018
Q1
$244M Buy
3,081,952
+56,021
+2% +$4.67M 0.44% 33
2017
Q4
$278M Buy
3,025,931
+29,561
+1% +$2.66M 0.51% 32
2017
Q3
$273M Buy
2,996,370
+59,015
+2% +$5.37M 0.55% 25
2017
Q2
$256M Sell
2,937,355
-76,309
-3% -$6.73M 0.55% 26
2017
Q1
$271M Sell
3,013,664
-249,376
-8% -$22.1M 0.63% 21
2016
Q4
$274M Buy
3,263,040
+44,340
+1% +$3.78M 0.7% 18
2016
Q3
$289M Buy
3,218,700
+276,071
+9% +$24M 0.79% 14
2016
Q2
$249M Buy
2,942,629
+171,523
+6% +$14.1M 0.78% 13
2016
Q1
$228M Buy
2,771,106
+134,859
+5% +$10.9M 0.77% 14
2015
Q4
$209M Buy
2,636,247
+78,468
+3% +$6M 0.75% 14
2015
Q3
$184M Buy
2,557,779
+343,962
+16% +$25.8M 0.75% 14
2015
Q2
$173M Buy
2,213,817
+348,835
+19% +$28.1M 0.66% 15
2015
Q1
$153M Buy
1,864,982
+46,654
+3% +$4.01M 0.67% 14
2014
Q4
$166M Buy
1,818,328
+291,761
+19% +$25.7M 0.81% 10
2014
Q3
$128M Buy
1,526,567
+409,126
+37% +$33.5M 0.73% 15
2014
Q2
$87.8M Buy
1,117,441
+35,249
+3% +$2.84M 0.54% 25
2014
Q1
$87.2M Buy
1,082,192
+149,631
+16% +$11.8M 0.6% 18
2013
Q4
$75.9M Buy
932,561
+105,616
+13% +$8.6M 0.57% 23
2013
Q3
$62.5M Buy
826,945
+1,744
+0.2% +$139K 0.54% 27
2013
Q2
$63.5M Buy
+825,201
New +$64.8M 0.6% 22

Other funds holding PG

Raymond James & Associates's PG Position: Q3 2024 in Review

Raymond James & Associates increased its Procter & Gamble (PG) stake by 3.1% in Q3 2024, buying an estimated $18.1M and bringing the position to 3,572,600 shares worth $619M. The position accounts for 0.38% of the portfolio, ranked #47.

Raymond James & Associates first reported a position in PG in Q2 2013 and has held it in 46 quarters since. 3,718 funds tracked by Wall St. Rank hold PG as of Q3 2024.

  • Raymond James & Associates held 3,572,600 shares of Procter & Gamble worth $619M as of Q3 2024.
  • Raymond James & Associates bought 106,584 Procter & Gamble shares in Q3 2024, an estimated $18.1M.
  • Procter & Gamble made up 0.38% of Raymond James & Associates's portfolio in Q3 2024, its #47 holding.
  • Raymond James & Associates first reported a position in Procter & Gamble in Q2 2013 and has held it in 46 quarters since.
  • 3,718 funds tracked by Wall St. Rank held Procter & Gamble as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.